Trade Summary

10 months ago, Orbimed Advisors LLC, serving as Dir at Shattuck Labs, Inc. (STTK), purchased 6,306,127 shares at $0.87 per share, for a total transaction value of $5,471,826.00. Following this transaction, Orbimed Advisors LLC now holds 1,051,021 shares of STTK.

This purchase represents a 120.00% decrease in Orbimed Advisors LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 25, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 2, 2025 at 9:52 PM ET, 8 days after the trade was made.

Shattuck Labs, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.